Advanced Oncotherapy announced the following changes to its Board of Directors. Mr. Gabriel Urwitz, Mr. Peter Sjöstrand, Mr. Chunlin "Allen" Han, and Dr. Yuelong Huang (all Non-Executive Directors of the Company), will step down from the Board and not seek re-election at the company's upcoming Annual General Meeting which is expected to be held in July 2020. Once these Board changes become effective in July 2020, the Board will decrease from 12 members to eight members and will comprise of three executive directors and five non-executive directors.